IsoPlexis is accelerating the fight against our toughest diseases by revealing the true functional biology of every patient cell. Our true functional single-cell biology uniquely reveals correlates that lead to discoveries in immunotherapy and beyond. Mission: Highly Personalized Medicine IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise, award-winning detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage.
1 to 50
TypeCompany - Private
RevenueLess than $1 million (USD)
IndustryUnknown
CompetitorsUnknown
Founded